Research sheds light on health outcomes and insurance coverage for patients treated with GLP-1s, and how technology is innovating obesity care "At Ro, we believe that better obesity care begins by listening to patients and measuring their outcomes," said Dr. Melynda Barnes, Chief Medical Officer at Ro. "Few organizations have the platform or scale to generate insights across such a wide range of topics with large sample sizes the way Ro does.